Kemp Proteins Establishes a Strategic Partnership with NeuImmune to Implement the geCHO Technology to Advance Precision Protein Production
Glycoengineered CHO technology expands Kemp's ability to control protein development, characterization, and production FREDERICK, Md., Sept. 17, 2026 /PRNewswire/ -- Kemp Proteins, LLC is expanding its cell line development and recombinant protein production capabilities through a...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.